Alkermes Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkermes Plc with three other
pharmaceutical manufacturers in Europe:
sales of 807.43 million Euros [US$978.70 million]
of which 66%
was Own Network (Spain)),
Dermapharm Holding SE
(793.83 million Euros [US$962.22 million]
of which 59%
was Pharmaceuticals and other products), and
based in FRANCE
(934.20 million Euros [US$1.13 billion]
of which 58%
was Companion Animals).
During the first
quarter of 2021, sales at Alkermes Plc totalled
209.90 million Euro.
This is a drop of 2.2%
from the 214.62 million Euro in sales at the company during the first quarter in 2020.
Sales at Alkermes Plc appear to have some seasonality: during each of the previous 8
years, sales have been highest during the fourth quarter, which has accounted for
between 26.0% and 35.2%
of the annual
Alkermes Plc reported sales of 905.43 million Euro (US$1.10 billion)
December of 2020.
decrease of 13.6%
versus 2019, when the company's sales were 1.05 billion Euro.